Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 726 - 750 of 2342 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI01
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type IV H(d18:1/16:0)
44260228 1534.860678 C72H130N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BM01
  • Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260468 1534.860678 C72H130N2O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AK01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260564 1534.860678 C72H130N2O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AE01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type I B antigen(d18:1/16:0)
44260644 1534.860678 C72H130N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AE01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type II B antigen(d18:1/16:0)
44261004 1534.860678 C72H130N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV01
  • Gala 1-3Lex(d18:1/16:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261548 1534.860678 C72H130N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AW01
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261612 1534.860678 C72H130N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BB01
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261636 1534.860678 C72H130N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AN02
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260269 1537.860344 C72H131NO33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC07
  • Forssman antigen(d18:1/24:1(15Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260186 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD07
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Para-Forssman x3b(d18:1/24:1(15Z))
44260194 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BC07
  • GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260394 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BD07
  • GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260402 1539.938867 C76H137N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AC07
  • GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260506 1539.938867 C76H137N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AE07
  • GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260522 1539.938867 C76H137N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AO07
  • GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260602 1539.938867 C76H137N3O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AJ07
  • GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260690 1539.938867 C76H137N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AK07
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • nLc5Cer(d18:1/24:1(15Z))
44261058 1539.938867 C76H137N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BN07
  • GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • P antigen(d18:1/24:1(15Z))
44261290 1539.938867 C76H137N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CE07
  • GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261426 1539.938867 C76H137N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AD07
  • Forssman-like iGb4(d18:1/24:1(15Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261866 1539.938867 C76H137N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AO07
  • GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261930 1539.938867 C76H137N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BG07
  • GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261682 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC05
  • Forssman antigen(d18:1/24:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260184 1541.954517 C76H139N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD05
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Para-Forssman x3b(d18:1/24:0)
44260192 1541.954517 C76H139N3O28

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024